0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioabsorbable Eluting Coronary Stent System Market by Product Type, Drug Type, Polymer Type, Indication, End User - Global Forecast to 2030- Product Image
Bioabsorbable Eluting Coronary Stent System Market by Product Type, Drug Type, Polymer Type, Indication, End User - Global Forecast to 2030- Product Image
Sale

Bioabsorbable Eluting Coronary Stent System Market by Product Type, Drug Type, Polymer Type, Indication, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082253
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Revolutionizing Coronary Care with Bioabsorbable Stents

The advent of bioabsorbable eluting coronary stents represents a pivotal shift in interventional cardiology, offering a resorbable scaffold that supports vessel healing without the long-term complications associated with permanent implants. These next-generation devices combine advanced polymer science with established drug-elution technologies to mitigate restenosis while gradually dissolving, thereby restoring natural vessel physiology. As cardiovascular disease remains a leading cause of morbidity and mortality worldwide, the promise of a temporary scaffold that delivers targeted pharmacotherapy and then disappears has attracted intense interest from clinicians, regulators, and payers alike.

This report delves into the current landscape of the bioabsorbable eluting stent market, charting its evolution from first-generation prototypes to today’s sophisticated constructs that utilize biodegradable polymers and refined drug coatings. We explore the clinical rationale underpinning their development, including reduced late-stage thrombosis and improved vessel remodeling, alongside the rigorous regulatory pathways that have shaped their adoption. By framing these technologies within the broader context of minimally invasive cardiology, this introduction sets the stage for a comprehensive examination of market drivers, challenges, and strategic imperatives.

Emerging Forces Redefining the Coronary Stent Landscape

A convergence of material science breakthroughs, shifting clinical paradigms, and patient-centric value propositions is redefining the coronary stent market. The initial craze for permanent metallic scaffolds has given way to a preference for devices that fulfill their therapeutic role before vanishing from the vessel. Innovations in polymer formulations have accelerated degradation profiles while preserving radial strength, and the incorporation of next-generation antiproliferative agents has optimized drug delivery kinetics.

Simultaneously, a wave of real-world evidence and long-term follow-up studies has bolstered clinician confidence in the safety and efficacy of resorbable scaffolds. Regulatory bodies are adapting their evaluation frameworks to accommodate these hybrid constructs, fostering a dynamic environment where iterative design improvements are rapidly integrated. The shift toward value-based care models further amplifies the appeal of bioabsorbable solutions, as healthcare systems seek to balance upfront costs with long-term outcomes and retransplantation risks. These transformative forces underscore a market in flux, ripe for companies agile enough to harness emerging technologies and deliver compelling clinical and economic benefits.

Tariff Repercussions Shaping the U.S. Bioabsorbable Stent Market

New tariff measures implemented in early 2025 have introduced incremental duties on imported medical devices and raw polymer materials, notably impacting manufacturers reliant on cross-border supply chains. The additional levies on biodegradable polymers and drug compounds have raised production costs, squeezing margins and prompting reconsideration of pricing strategies. Devices that once benefited from cost-competitive sourcing must now navigate altered procurement dynamics, with some firms electing to localize manufacturing or renegotiate supply agreements to preserve profitability.

Beyond direct cost implications, the tariffs have amplified pressure on reimbursement negotiations, particularly in markets where hospitals and specialty centers operate under fixed-budget constraints. Stakeholders are reevaluating value propositions, demanding robust evidence of long-term cost savings and clinical superiority. In response, manufacturers are intensifying collaborations with local partners to mitigate duty exposure and enhance distribution efficiency. While these measures require upfront investment, they also present an opportunity to reinforce market positioning through shortened lead times and stronger regional footprints. Ultimately, the cumulative impact of the 2025 tariffs is reshaping global strategies, incentivizing vertical integration and supply chain resilience.

Unveiling Core Market Divisions Driving Innovation

A nuanced view of market segmentation reveals key pockets of growth and innovation. In the realm of product typologies, balloon expandable constructs dominate early adoption due to their familiar deployment mechanisms, while self-expandable alternatives are gaining traction for complex anatomies requiring adaptive radial force. Drug modalities further differentiate competitive offerings, with Biolimus-coated platforms seeking to optimize polymer compatibility, Everolimus systems leveraging extensive clinical validation, and Sirolimus variants emphasizing potent antiproliferative effects.

Polymer choices underscore another axis of strategic differentiation. Poly-L-Lactic Acid formulations remain the cornerstone of bioabsorbable scaffolds, prized for their predictable resorption kinetics, whereas Polycaprolactone iterations are emerging as candidates for extended support durations. Clinical indications drive device customization, as acute coronary syndrome presentations-including non-ST elevation myocardial infarction, ST-elevation myocardial infarction, and unstable angina-demand rapid lesion stabilization, while stable angina cases call for durable relief with minimal long-term vessel trauma. Finally, adoption dynamics vary across end-user channels: ambulatory surgical centers emphasize throughput and cost-efficiency; cardiac specialty centers prioritize cutting-edge protocols and specialized training; and hospitals, subdivided into secondary and tertiary institutions, balance volume with referral complexity. These intertwined dimensions illuminate where future investment and clinical focus will yield the greatest returns.

Regional Dynamics Steering Market Growth Trajectories

Regional contours shape the trajectory of bioabsorbable stent adoption. In the Americas, robust reimbursement frameworks and a high prevalence of percutaneous coronary interventions bolster uptake, with physicians in the United States often leading early-stage clinical trials and extending indications. Stakeholders here prioritize devices backed by comprehensive longitudinal data, reflective of a payer environment that rewards demonstrable improvements in long-term outcomes.

Across Europe, Middle East & Africa, a mosaic of regulatory regimes and healthcare infrastructures dictates market penetration. Western European nations provide established pathways for premium device reimbursement, while emerging economies within the region remain sensitive to cost pressures. Manufacturers seeking to expand their footprint must navigate diverse regulatory approvals and tailor value dossiers to local health technology assessment criteria.

Asia-Pacific markets are distinguished by dynamic growth trajectories driven by rising cardiovascular disease burden and rapid expansion of interventional cardiology centers. In China and India, government initiatives to modernize healthcare infrastructure and enhance access to advanced therapies create fertile ground for market entrants. Yet price sensitivity and evolving local competition necessitate flexible pricing structures and partnerships with regional distributors to achieve sustainable scale.

Competitive Pulse: Leaders in Bioabsorbable Stent Development

A cadre of innovative companies is propelling the bioabsorbable stent field forward. Leading medtech players have leveraged their extensive distribution networks and clinical trial expertise to introduce second-generation resorbable scaffolds with refined degradation profiles. At the same time, nimble specialized firms are focusing on niche polymers and drug combinations, seeking to carve out defensible positions in high-risk patient subsets.

Strategic alliances and licensing agreements abound, as device developers collaborate with pharmaceutical innovators to optimize drug-eluting matrices. In parallel, established cardiovascular device manufacturers are pursuing acquisitions of smaller biotech firms to integrate novel polymer technologies into their portfolios. Capital investment is increasingly directed toward centers of excellence in catheterization, underscoring the importance of procedural training and post-market surveillance in shaping physician adoption curves. This competitive pulse is driving a wave of product refinements and proof-of-concept studies that will inform the next chapter of clinical validation and commercial scaling.

Strategic Imperatives for Industry Trailblazers

Industry players must adopt a multifaceted approach to sustain momentum. First, prioritizing R&D investment in advanced polymer chemistry and controlled-release drug coatings will enable differentiation through performance and safety enhancements. Second, establishing localized manufacturing or forging strategic partnerships can mitigate the impact of cross-border tariffs and foster supply chain agility. Third, engaging payers early with robust health economic models and real-world evidence will streamline reimbursement negotiations and highlight long-term value propositions.

Simultaneously, expanding clinical education programs in emerging markets will accelerate physician familiarity and procedural proficiency, driving adoption in high-volume intervention centers. Data-driven marketing strategies that leverage digital platforms can support targeted outreach to interventional cardiologists and hospital procurement teams. Finally, exploring adjacent applications-such as peripheral vascular and neurovascular interventions-can unlock new growth avenues while maximizing returns on existing polymer and drug elution technologies. By aligning these imperatives with organizational capabilities, manufacturers can navigate complexity and secure leadership in a rapidly evolving market.

Rigorous Analytical Framework Underpinning the Research

This analysis is grounded in a rigorous methodology that combines exhaustive secondary research with in-depth primary engagements. The secondary phase encompassed the review of peer-reviewed journals, regulatory filings, patent databases, corporate financial disclosures, and industry white papers. Additionally, global trade data and tariff schedules were examined to quantify the impact of recent policy changes on material sourcing and device pricing.

The primary research component involved structured interviews with interventional cardiologists, procurement leaders, regulatory experts, and payers across key regions. These conversations provided granular insights into clinical adoption drivers, reimbursement hurdles, and supply chain risk mitigation strategies. Data triangulation techniques were employed to cross-validate findings, ensuring methodological robustness and reducing bias. The resulting synthesis was subjected to an internal quality assurance review, reaffirming the accuracy and relevance of the segmentation frameworks, competitive analyses, and strategic recommendations presented herein.

Synthesis of Insights and Future Outlook

The bioabsorbable eluting coronary stent sector stands at a crossroads, fueled by technological innovation, evolving clinical guidelines, and shifting policy landscapes. Material and manufacturing advances have addressed early safety concerns, while emerging real-world data continues to underscore the promise of temporary scaffolding solutions. Yet the industry must grapple with external pressures, including tariffs and reimbursement dynamics, that challenge traditional market entry models.

As the competitive landscape intensifies, success will hinge on the ability to integrate scientific breakthroughs with compelling health economic narratives and agile operational strategies. Companies that can anticipate regional nuances, collaborate seamlessly with clinical stakeholders, and demonstrate clear long-term benefits will shape the next wave of growth. The conclusions drawn here offer a strategic lens through which organizations can prioritize investments, refine go-to-market plans, and deliver transformative improvements in coronary care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Balloon Expandable
    • Self Expandable
  • Drug Type
    • Biolimus
    • Everolimus
    • Sirolimus
  • Polymer Type
    • Poly-L-Lactic Acid
    • Polycaprolactone
  • Indication
    • Acute Coronary Syndrome
      • Non-ST Elevation Myocardial Infarction
      • ST Elevation Myocardial Infarction
      • Unstable Angina
    • Stable Angina
  • End User
    • Ambulatory Surgical Centers
    • Cardiac Specialty Centers
    • Hospitals
      • Secondary Hospitals
      • Tertiary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik GmbH & Co. KG
  • Elixir Medical Corporation
  • Reva Medical, Inc.
  • Svelte Medical Systems Ltd.
  • Arterius Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioabsorbable Eluting Coronary Stent System Market, by Product Type
8.1. Introduction
8.2. Balloon Expandable
8.3. Self Expandable
9. Bioabsorbable Eluting Coronary Stent System Market, by Drug Type
9.1. Introduction
9.2. Biolimus
9.3. Everolimus
9.4. Sirolimus
10. Bioabsorbable Eluting Coronary Stent System Market, by Polymer Type
10.1. Introduction
10.2. Poly-L-Lactic Acid
10.3. Polycaprolactone
11. Bioabsorbable Eluting Coronary Stent System Market, by Indication
11.1. Introduction
11.2. Acute Coronary Syndrome
11.2.1. Non-ST Elevation Myocardial Infarction
11.2.2. ST Elevation Myocardial Infarction
11.2.3. Unstable Angina
11.3. Stable Angina
12. Bioabsorbable Eluting Coronary Stent System Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Cardiac Specialty Centers
12.4. Hospitals
12.4.1. Secondary Hospitals
12.4.2. Tertiary Hospitals
13. Americas Bioabsorbable Eluting Coronary Stent System Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bioabsorbable Eluting Coronary Stent System Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Boston Scientific Corporation
16.3.3. Biotronik GmbH & Co. KG
16.3.4. Elixir Medical Corporation
16.3.5. Reva Medical, Inc.
16.3.6. Svelte Medical Systems Ltd.
16.3.7. Arterius Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BIOLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EVEROLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SIROLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY NON-ST ELEVATION MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ST ELEVATION MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 51. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 101. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. FRANCE BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 113. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 115. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ITALY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 120. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 122. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 147. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 148. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 150. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 164. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 171. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 192. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EGYPT BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 197. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 199. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 201. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 213. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 215. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 217. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 220. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 237. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 239. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 242. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. CHINA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 246. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 247. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 248. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 249. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. INDIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 253. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA BIOABSORBABLE ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA BIOABSORBABLE ELUTING CORONARY

Companies Mentioned

The companies profiled in this Bioabsorbable Eluting Coronary Stent System market report include:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik GmbH & Co. KG
  • Elixir Medical Corporation
  • Reva Medical, Inc.
  • Svelte Medical Systems Ltd.
  • Arterius Limited

Methodology

Methodology DOWNLOAD NOW

Related Topics

Related Reports

Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type, Indication, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type, Indication, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
EUR$3,250USDGBP
EUR$4,850USDGBP
Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2024-2032 - Product Image

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
EUR$2,999USDGBP
Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
EUR$4,750USDGBP
Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • Global
From
EUR$7,500USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more